These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 10752923)

  • 1. Effect of misoprostol on the secretion of histamine from basophils of whole blood.
    Babakhin AA; Nolte H; DuBuske LM
    Ann Allergy Asthma Immunol; 2000 Mar; 84(3):361-5. PubMed ID: 10752923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotypic analysis of grass pollen-specific antibodies in human plasma. 4. Biological activity of allergen-specific and autoanti-IgE antibody fractions on basophil histamine release.
    Batard T; Weyer A; Laroze A; Ickovic MR; David B; Peltre G; Basuyaux B
    Clin Exp Allergy; 1996 Nov; 26(11):1308-15. PubMed ID: 8955580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc.
    Marone G; Findlay SR; Lichtenstein LM
    J Pharmacol Exp Ther; 1981 May; 217(2):292-8. PubMed ID: 6164779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.
    Cirillo R; Triggiani M; Siri L; Ciccarelli A; Pettit GR; Condorelli M; Marone G
    J Immunol; 1990 May; 144(10):3891-7. PubMed ID: 1692065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgE-dependent IL-4 secretion by human basophils. The relationship between cytokine production and histamine release in mixed leukocyte cultures.
    Schroeder JT; MacGlashan DW; Kagey-Sobotka A; White JM; Lichtenstein LM
    J Immunol; 1994 Aug; 153(4):1808-17. PubMed ID: 7519213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action.
    Schleimer RP; MacGlashan DW; Gillespie E; Lichtenstein LM
    J Immunol; 1982 Oct; 129(4):1632-6. PubMed ID: 6180017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism.
    Farnam J; Grant JA; Lett-Brown MA; Hunt C; Thueson DO; Giclas PC
    J Immunol; 1985 Jan; 134(1):541-7. PubMed ID: 2578053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G; Poto S; Celestino D; Bonini S
    J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
    Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
    J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgE-dependent regulation of human basophil adherence to vascular endothelium.
    Bochner BS; MacGlashan DW; Marcotte GV; Schleimer RP
    J Immunol; 1989 May; 142(9):3180-6. PubMed ID: 2468714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pertussis toxin on mediator release from human basophils.
    Warner JA; Yancey KB; MacGlashan DW
    J Immunol; 1987 Jul; 139(1):161-5. PubMed ID: 2438348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mercuric chloride enhances immunoglobulin E-dependent mediator release from human basophils.
    Strenzke N; Grabbe J; Plath KE; Rohwer J; Wolff HH; Gibbs BF
    Toxicol Appl Pharmacol; 2001 Aug; 174(3):257-63. PubMed ID: 11485386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils.
    Casolaro V; Spadaro G; Patella V; Marone G
    J Immunol; 1993 Nov; 151(10):5563-73. PubMed ID: 7693814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prostaglandin D2 in modulating histamine release from human basophils.
    Peters SP; Kagey-Sobotka A; MacGlashan DW; Lichtenstein LM
    J Pharmacol Exp Ther; 1984 Feb; 228(2):400-6. PubMed ID: 6198512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-3-induced histamine release from human basophils. Dissociation from cationic dye binding and down-regulation by Na+ and K+.
    Tedeschi A; Palella M; Milazzo N; Lorini M; Miadonna A
    J Immunol; 1995 Sep; 155(5):2652-60. PubMed ID: 7544380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nicotine on basophil histamine release.
    Thompson-Cree ME; Stevenson MR; Shields MD; Ennis M
    Inflamm Res; 2004 May; 53(5):211-4. PubMed ID: 15105971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basophil histamine release decreases during omalizumab therapy in allergic asthmatics.
    Noga O; Hanf G; Kunkel G; Kleine-Tebbe J
    Int Arch Allergy Immunol; 2008; 146(1):66-70. PubMed ID: 18087163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of mediator release from human basophils induced by platelet-activating factor.
    Columbo M; Casolaro V; Warner JA; MacGlashan DW; Kagey-Sobotka A; Lichtenstein LM
    J Immunol; 1990 Dec; 145(11):3855-61. PubMed ID: 1700998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.